Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Dr Reddy’s Laboratories ( (RDY) ) has provided an update.
Dr. Reddy’s Laboratories announced the release of an audio recording of their earnings call for the quarter ending December 31, 2024. Conducted on January 23, 2025, this release aligns with the company’s compliance under the Securities and Exchange Board of India’s regulations, showing their commitment to transparency and communication with stakeholders.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a prominent pharmaceutical company based in Hyderabad, India. It specializes in the manufacture of generic medications and active pharmaceutical ingredients, focusing on providing affordable healthcare products worldwide.
YTD Price Performance: -9.70%
Average Trading Volume: 1,485,577
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $12.44B
See more insights into RDY stock on TipRanks’ Stock Analysis page.
